ES2033747T3 - Preparacion de polipeptidos relacionados con factores de ligacion. - Google Patents
Preparacion de polipeptidos relacionados con factores de ligacion.Info
- Publication number
- ES2033747T3 ES2033747T3 ES198787110458T ES87110458T ES2033747T3 ES 2033747 T3 ES2033747 T3 ES 2033747T3 ES 198787110458 T ES198787110458 T ES 198787110458T ES 87110458 T ES87110458 T ES 87110458T ES 2033747 T3 ES2033747 T3 ES 2033747T3
- Authority
- ES
- Spain
- Prior art keywords
- guests
- preparation
- polypeptides related
- polypeptides
- factors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A POLIPEPTIDOS RELACIONADOS CON LOS FACTORES DE FIJACION DE LA INMUNOGLOBULINA E HUMANA (IGE-BFS), MRNAS, ADNS Y VECTORES HIBRIDOS QUE CODIFICAN DICHOS POLIPEPTIDOS, HUESPED QUE CONTIENE DICHOS VECTORES HIBRIDOS, PROCEDIMIENTO PARA LA PREPARACION DE DICHOS POLIPEPTIDOS, MRNAS, ADNS, VECTORES HIBRIDOS Y HUESPEDES. LOS POLIPEPTIDOS PUEDEN UTILIZARSE PARA PREVENIR Y/O TRATAR ENFERMEDADES ALERGICAS Y, POR CONSIGUIENTE, LA INVENCION CONCIERNE TAMBIEN A PREPARACIONES FARMACEUTICAS QUE LOS CONTIENEN.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868617862A GB8617862D0 (en) | 1986-07-22 | 1986-07-22 | Binding factor related polypeptides |
GB868626622A GB8626622D0 (en) | 1986-07-22 | 1986-11-07 | Polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2033747T3 true ES2033747T3 (es) | 1993-04-01 |
Family
ID=26291074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198787110458T Expired - Lifetime ES2033747T3 (es) | 1986-07-22 | 1987-07-20 | Preparacion de polipeptidos relacionados con factores de ligacion. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5081028A (es) |
EP (1) | EP0254249B1 (es) |
JP (2) | JP2713912B2 (es) |
AU (1) | AU602907B2 (es) |
DE (1) | DE3781217T2 (es) |
DK (1) | DK172259B1 (es) |
ES (1) | ES2033747T3 (es) |
GR (1) | GR3006306T3 (es) |
IE (1) | IE60393B1 (es) |
PT (1) | PT85364B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5272255A (en) * | 1985-01-26 | 1993-12-21 | Ciba-Geigy Corporation | Polypeptide factors from colostrum |
GB8514732D0 (en) * | 1985-06-11 | 1985-07-10 | Ciba Geigy Ag | Purified immunoglobulin-related factor |
DE3777245D1 (de) * | 1986-04-30 | 1992-04-16 | Junji Yodoi | Protein und verfahren zu dessen herstellung. |
EP0259585B1 (en) * | 1986-07-29 | 1993-06-09 | Kishimoto, Tadamitsu, Prof. | Monoclonal antibodies specific to surface receptor for ige and hybrid cell lines producing these antibodies and use thereof |
AU628034B2 (en) * | 1987-11-19 | 1992-09-10 | 3I Research Exploitation Limited | Immunoglobulin e competitor |
GB8727045D0 (en) * | 1987-11-19 | 1987-12-23 | Research Corp Ltd | Immunoglobulin e competitor |
GB9010356D0 (en) * | 1990-05-09 | 1990-06-27 | Ciba Geigy Ag | Maturation of hemopoietic cells |
US7923250B2 (en) | 1997-07-30 | 2011-04-12 | Warsaw Orthopedic, Inc. | Methods of expressing LIM mineralization protein in non-osseous cells |
ATE417927T1 (de) * | 1997-07-30 | 2009-01-15 | Univ Emory | Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme |
DE19746874A1 (de) * | 1997-10-23 | 1999-04-29 | Qiagen Gmbh | Verfahren zur Isolierung und Reinigung von Nukleinsäuren an hydrophoben Oberflächen - insbesondere unter Verwendung hydrophober Membranen |
US6410714B1 (en) * | 1999-03-24 | 2002-06-25 | Heska Corporation | Canine low affinity IgE receptor (CD23) nucleic acid molecules and uses thereof |
DE10147439B4 (de) * | 2001-09-26 | 2014-01-30 | Qiagen Gmbh | Verfahren zur Isolierung von DNA aus biologischen Proben |
EP1602720B1 (en) * | 2003-03-05 | 2010-11-03 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Process for producing heterologous protein in e. coli |
JP2009131151A (ja) * | 2006-02-28 | 2009-06-18 | Osaka Univ | PILRαと結合するポリペプチド、およびそれをコードするポリヌクレオチド、並びにその利用 |
WO2011068853A2 (en) * | 2009-12-01 | 2011-06-09 | Boston Medical Center Corporation | TREATMENT OF IgE-MEDIATED DISEASE |
JP6911577B2 (ja) * | 2017-06-28 | 2021-07-28 | 住友ゴム工業株式会社 | 二輪自動車用タイヤ |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK159976C (da) * | 1979-06-01 | 1991-05-27 | Searle & Co | Plasmidvektorer, fremgangsmaade til fremstilling deraf, bakterieceller transformeret med plasmidvektorer samt udtrykkelse af protein i transformerede bakterieceller |
US4666847A (en) * | 1981-01-16 | 1987-05-19 | Collaborative Research, Inc. | Recombinant DNA means and method |
US4740461A (en) * | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
US4758511A (en) * | 1984-03-16 | 1988-07-19 | Dnax Research Institute Of Molecular And Cellular Biology, Inc. | CDNA clones coding for polypeptides exhibiting IGE binding factor activity |
JPS61268184A (ja) * | 1984-11-05 | 1986-11-27 | Green Cross Corp:The | 組換えプラスミド及び当該プラスミドによる形質転換株 |
EP0218700A4 (en) * | 1985-04-23 | 1988-09-19 | Medical Biology Inst | IDENTIFICATION OF AN IgE BINDING PROTEIN BY MOLECULAR CLONING. |
US4946788A (en) * | 1985-06-11 | 1990-08-07 | Ciba-Geigy Corporation | Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications |
DE3777245D1 (de) * | 1986-04-30 | 1992-04-16 | Junji Yodoi | Protein und verfahren zu dessen herstellung. |
JPH085917B2 (ja) * | 1986-04-30 | 1996-01-24 | 淳司 淀井 | 新規な蛋白質およびその製法 |
EP0259615A1 (en) * | 1986-08-21 | 1988-03-16 | Kishimoto, Tadamitsu, Prof. | Human low affinity Fc epsilon-receptor, the isolation, the recombinant preparation and purification thereof |
EP0257114A1 (en) * | 1986-08-21 | 1988-03-02 | Kishimoto, Tadamitsu, Prof. | Human low affinity Fc epsilon-receptor, the isolation and purification thereof |
WO1988003172A1 (en) * | 1986-10-28 | 1988-05-05 | Memorial Sloan-Kettering Cancer Center | DNA EXPRESSING Fc RECEPTOR PROTEIN |
JPH07107079A (ja) * | 1993-10-07 | 1995-04-21 | Hitachi Ltd | 周波数位相同期回路および情報転送周波数変換回路ならびに通信端末装置 |
-
1987
- 1987-07-20 EP EP87110458A patent/EP0254249B1/en not_active Expired - Lifetime
- 1987-07-20 DE DE8787110458T patent/DE3781217T2/de not_active Expired - Lifetime
- 1987-07-20 ES ES198787110458T patent/ES2033747T3/es not_active Expired - Lifetime
- 1987-07-20 PT PT85364A patent/PT85364B/pt not_active IP Right Cessation
- 1987-07-21 IE IE196787A patent/IE60393B1/en not_active IP Right Cessation
- 1987-07-21 AU AU75947/87A patent/AU602907B2/en not_active Ceased
- 1987-07-21 DK DK381287A patent/DK172259B1/da not_active IP Right Cessation
- 1987-07-21 JP JP62180164A patent/JP2713912B2/ja not_active Expired - Lifetime
-
1990
- 1990-11-21 US US07/617,487 patent/US5081028A/en not_active Expired - Fee Related
-
1992
- 1992-11-20 GR GR920402189T patent/GR3006306T3/el unknown
-
1995
- 1995-11-30 JP JP7313369A patent/JP2619232B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5081028A (en) | 1992-01-14 |
DK381287A (da) | 1988-01-23 |
PT85364B (pt) | 1990-04-30 |
AU602907B2 (en) | 1990-11-01 |
IE871967L (en) | 1989-01-22 |
DK172259B1 (da) | 1998-02-09 |
DE3781217D1 (de) | 1992-09-24 |
EP0254249A1 (en) | 1988-01-27 |
JP2619232B2 (ja) | 1997-06-11 |
DK381287D0 (da) | 1987-07-21 |
JPS6368097A (ja) | 1988-03-26 |
PT85364A (en) | 1987-08-01 |
DE3781217T2 (de) | 1992-12-17 |
JPH08242865A (ja) | 1996-09-24 |
IE60393B1 (en) | 1994-07-13 |
GR3006306T3 (es) | 1993-06-21 |
JP2713912B2 (ja) | 1998-02-16 |
AU7594787A (en) | 1988-02-18 |
EP0254249B1 (en) | 1992-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2033747T3 (es) | Preparacion de polipeptidos relacionados con factores de ligacion. | |
IT8467445A1 (it) | Composizione e preparato per la somministrazione di medicamenti per via cutanea. | |
PT80292B (pt) | Preparacao de factor viii humano funcional | |
KR880009035A (ko) | Apc 폴리펩티드의 전구 단백질, 이를 위한 dna 암호화, 및 이 dna와 단백질의 진단 용도 | |
DK552684A (da) | Desulfatohirudiner samt deres fremstilling og anvendelse | |
ES520985A0 (es) | Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios. | |
DK173883D0 (da) | Substituerede 8-phenylxanthiner | |
DK43890D0 (da) | Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse | |
DK184890A (da) | Anvendelse af anti-t-celle-immunotoxin til fremstilling af farmaceutiske praeparater til behandling af autoimmune sygdomme | |
DK164063C (da) | Fremgangsmaade til fremstilling af praktisk taget rent uglycosyleret rekombinant humant immuninterferonprotein | |
DK467487A (da) | Polypeptid, anvendeligt til lindring, behandling og diagnosticering af autoimmunitetssygdomme, isaer arthritis | |
NO167357C (no) | Kosmetiske preparater for regenerering og hydratisering av hud samt fremgangsmaate for fremstilling av slike preparater. | |
AR227021A1 (es) | Procedimiento de preparacion de concentrados de complejo protrombinico altamente purificado | |
NO872551D0 (no) | Fremgangsmaate for fremstilling av farmasoeytiske preparater | |
DK280282A (da) | Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider | |
NO159695C (no) | Vannfri antitranspirasjons- og/eller deodorantkrem og fremstilling av denne. | |
IT1224574B (it) | Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono | |
AR230568A1 (es) | Composicion cosmetica para la higiene femenina intima | |
DK0417003T3 (da) | Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation | |
NO167255C (no) | Kosmetisk preparat for regenerering av hud og fremgangsmaate for fremstilling av preparatet | |
DK675389D0 (da) | Terapeutiske praeparater til forebyggelse af fibrinaflejringer | |
IT1181883B (it) | Composizioni cosmetiche comrendenti estratti lisati di hafnia e procedimento per la loro preparazione | |
DK273585D0 (da) | Fremgangsmaade til fremstilling af medicinske kosmetiske praeparater | |
NO874200D0 (no) | Fremgangsmaate for fremstilling av farmasoeytiske preparater | |
IT1211463B (it) | Composizione liquida per il trattamento preventivo e curativo di malattie crittogamiche di tipo oidio e procedimento per la messa in opera di tale composizione |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 254249 Country of ref document: ES |